Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Operating Expenses | 17,665 | 16,042 | 0 | 0 |
| Operating Income | -17,665 | -16,042 | N/A | N/A |
| Interest Expense | 252 | 76 | 0 | 0 |
| Other Income | 0 | -79 | 0 | 0 |
| Pre-tax Income | -17,917 | -16,197 | 0 | 0 |
| Net Income Continuous | -17,917 | -16,197 | N/A | N/A |
| Net Income | $-17,917 | $-16,197 | $N/A | $N/A |
| EPS Basic Total Ops | -22.72 | -4.06 | N/A | N/A |
| EPS Basic Continuous Ops | -19.18 | -9.54 | N/A | N/A |
| EPS Diluted Total Ops | -22.72 | -4.06 | N/A | N/A |
| EPS Diluted Continuous Ops | -19.18 | -9.54 | N/A | N/A |
| EBITDA(a) | $-17,478 | $-15,873 | $N/A | $N/A |